Development and prospects of dedicated tracers for the molecular imaging of bacterial infections

Bioconjugate Chemistry

Volumn 24, Issue 12, 2013, Pages 1971-1989

  Bunschoten, A ^a   Welling, M M ^a   Termaat, M F ^a   Sathekge, M ^b   Van Leeuwen, F W B ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA;

BACTERIA INFECTION; BACTERIAL INFECTIONS; CHEMICAL DESIGNS; CLINICAL MANAGEMENT; FURTHER DEVELOPMENT; HEALTHCARE PROBLEMS; OPTICAL-; PATIENT MANAGEMENT;

MOLECULAR IMAGING;

AMINOSUGAR; ANTHRACENE; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CECROPIN; CECROPIN P1; CEPHALOSPORIN; CIPROFLOXACIN; FLUORODEOXYGLUCOSE F 18; GALACTOSE; GLUCOSE; LACTOFERRIN; LINEZOLID; LIPOPOLYSACCHARIDE; MAGAININ 2; MANNOSE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE C 11; NISIN; PENICILLIN G; PHENOXAZINE DERIVATIVE; POLYMYXIN B; RADIOPHARMACEUTICAL AGENT; RAMOPLANIN; RIFAMPICIN; ROTAXANE; SORTASE; STREPTAVIDIN; TELAVANCIN; UNCLASSIFIED DRUG; VANCOMYCIN; ZINC DERIVATIVE;

AMINO ACID SEQUENCE; ANTIBIOTIC THERAPY; BACTERIAL CELL; BACTERIAL CELL WALL; BACTERIAL INFECTION; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BACTERIOPHAGE; BACTERIUM IDENTIFICATION; COMPUTER ASSISTED TOMOGRAPHY; DRUG HALF LIFE; DRUG MECHANISM; FLUORESCENCE IMAGING; FLUORESCENCE MICROSCOPY; FLUORESCENCE MOLECULAR TOMOGRAPHY; HUMAN; INNATE IMMUNITY; ISOTOPE LABELING; KIDNEY CLEARANCE; LIPID BILAYER; MOLECULAR IMAGING; NONHUMAN; PATIENT CARE; POSITRON EMISSION TOMOGRAPHY; QUORUM SENSING; REVIEW;

BACTERIA (MICROORGANISMS);

ANIMALS; BACTERIA; BACTERIAL INFECTIONS; HUMANS; ISOTOPE LABELING; MOLECULAR IMAGING; RADIOACTIVE TRACERS;

EID: 84890844091     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc4003037     Document Type: Review

References (212)

1. World Health Organisation (2010) WHO Report Global Tuberculosis Control, Geneva.
2. Palestro, C. J., Love, C., and Miller, T. T. (2006) Infection and musculoskeletal conditions: Imaging of musculoskeletal infections Best Pract. Res. Clin. Rheumatol. 20, 1197-1218
3. Thigpen, M. C., Whitney, C. G., Messonnier, N. E., Zell, E. R., Lynfield, R., Hadler, J. L., Harrison, L. H., Farley, M. M., Reingold, A., Bennett, N. M., Craig, A. S., Schaffner, W., Thomas, A., Lewis, M. M., Scallan, E., and Schuchat, A. (2011) Bacterial meningitis in the United States, 1998-2007 New Engl. J. Med. 364, 2016-2025
4. Gaca, J. G., Sheng, S., Daneshmand, M. A., O'Brien, S., Rankin, J. S., Brennan, J. M., Hughes, G. C., Glower, D. D., Gammie, J. S., and Smith, P. K. (2011) Outcomes for endocarditis surgery in North America: a simplified risk scoring system J. Thorac. Cardiovasc. Surg. 141, 98-106
5. Health protection agency (2009) Fifth report of the mandatory surveillance of surgical site infection in orthopaedic surgery, London.
6. Walter, C. J., Dumville, J. C., Sharp, C. A., and Page, T. (2012) Systematic review and meta-analysis of wound dressings in the prevention of surgical-site infections in surgical wounds healing by primary intention Br. J. Surg. 99, 1185-1194
7. Rahmim, A. and Zaidi, H. (2008) PET versus SPECT: strengths, limitations and challenges Nucl. Med. Commun. 29, 193-207
8. Buckle, T., van Leeuwen, A. C., Chin, P. T., Janssen, H., Muller, S. H., Jonkers, J., and van Leeuwen, F. W. B. (2010) A self-assembled multimodal complex for combined pre- and intraoperative imaging of the sentinel lymph node Nanotechnology 21, 355101
9. Brouwer, O. R., Klop, W. M. C., Buckle, T., van den Brekel, M. W. M., Balm, A. J. M., Nieweg, O. E., Valdés-Olmos, R. A., and van Leeuwen, F. W. B. (2012) Feasibility of sentinel node biopsy in head and neck melanoma using a hybrid radioactive and fluorescent tracer Ann. Surg. Oncol. 19, 1988-1994
10. Bunschoten, A., Buckle, T., Visser, N., Kuil, J., Yuan, H., Josephson, L., Vahrmeijer, A. L., and van Leeuwen, F. W. B. (2012) Multimodal interventional molecular imaging of tumor margins and distant metastases by targeting the αvβ3 integrin ChemBioChem 13, 1039-1045
11. Signore, A., Mather, S. J., Piaggio, G., Malviya, G., and Dierckx, R. A. (2010) Molecular imaging of inflammation/infection: nuclear medicine and optical imaging agents and methods Chem. Rev. 110, 3112-3145
12. Dorward, D. A., Lucas, C. D., Rossi, A. G., Haslett, C., and Dhaliwal, K. (2012) Imaging inflammation: Molecular strategies to visualize key components of the inflammatory cascade, from initiation to resolution Pharmacol. Ther. 135, 182-199
13. Lavender, J. P., Lowe, J., Barker, J. R., Burn, J. I., and Chaudhri, M. A. (1971) Gallium 67 citrate scanning in neoplastic and inflammatory lesions Br. J. Radiol. 44, 361-366
14. Tsan, M. F. (1985) Mechanism of Ga-67 Accumulation in Inflammatory Lesions J. Nucl. Med. 26, 88-92
15. Rizzello, A., Di Pierro, D., Lodi, F., Trespidi, S., Cicoria, G., Pancaldi, D., Nanni, C., Marengo, M., Marzola, M. C., Al-Nahhas, A., Rubello, D., and Boschi, S. (2009) Synthesis and quality control of 68Ga citrate for routine clinical PET Nucl. Med. Commun. 30, 542-545
16. Nanni, C., Errani, C., Boriani, L., Fantini, L., Ambrosini, V., Boschi, S., Rubello, D., Pettinato, C., Mercuri, M., Gasbarrini, A., and Fanti, S. (2010) 68Ga-citrate PET/CT for evaluating patients with infections of the bone: preliminary results J. Nucl. Med. 51, 1932-1936
17. Kumar, V., Boddeti, D. K., Evans, S. G., and Angelides, S. (2012) (68)Ga-Citrate-PET for diagnostic imaging of infection in rats and for intra-abdominal infection in a patient Curr. Radiopharm. 5, 71-75
18. McAfee, J. G. and Thakur, M. L. (1976) Survey of radioactive agents for in vitro labeling of phagocytic leukocytes. I. Soluble agents J. Nucl. Med. 17, 480-487
19. Peters, A. M., Danpure, H. J., Osman, S., Hawker, R. J., Henderson, B. L., Hodgson, H. J., Kelly, J. D., Neirinckx, R. D., and Lavender, J. P. (1986) Clinical experience with 99mTc-hexamethylpropylene-amineoxime for labelling leucocytes and imaging inflammation Lancet 2, 946-949
20. Datz, F. L. (1994) Indium-111-labeled leukocytes for the detection of infection: current status Semin. Nucl. Med. 24, 92-109
21. Forstrom, L. A., Mullan, B. P., Hung, J. C., Lowe, V. J., and Thorson, L. M. (2000) 18F-FDG labelling of human leukocytes Nucl. Med. Commun. 21, 691-694
22. Dumarey, N., Egrise, D., Blocklet, D., Stallenberg, B., Remmelink, M., del Marmol, V., Van Simaeys, G., Jacobs, F., and Goldman, S. (2006) Imaging infection with 18F-FDG-labeled leukocyte PET/CT: initial experience in 21 patients J. Nucl. Med. 47, 625-632
23. Dumarey, N. (2009) Imaging with FDG labeled leukocytes: is it clinically useful? Q. J. Nucl. Med. Mol. Im. 53, 89-94
24. Bhargava, K. K., Gupta, R. K., Nichols, K. J., and Palestro, C. J. (2009) In vitro human leukocyte labeling with (64)Cu: an intraindividual comparison with (111)In-oxine and (18)F-FDG Nucl. Med. Biol. 36, 545-549
25. Leevy, W. M., Johnson, J. R., Lakshmi, C., Morris, J., Marquez, M., and Smith, B. D. (2006) Selective recognition of bacterial membranes by zinc(II)-coordination complexes Chem. Commun. 1595-1597
26. Leevy, W. M., Gammon, S. T., Jiang, H., Johnson, J. R., Maxwell, D. J., Jackson, E. N., Marquez, M., Piwnica-Worms, D., and Smith, B. D. (2006) Optical imaging of bacterial infection in living mice using a fluorescent near-infrared molecular probe J. Am. Chem. Soc. 128, 16476-16477
27. Leevy, W. M., Gammon, S. T., Johnson, J. R., Lampkins, A. J., Jiang, H., Marquez, M., Piwnica-Worms, D., Suckow, M. A., and Smith, B. D. (2008) Noninvasive optical imaging of staphylococcus aureus bacterial infection in living mice using a Bis-dipicolylamine-Zinc(II) affinity group conjugated to a near-infrared fluorophore Bioconjugate Chem. 19, 686-692
28. Thakur, M. L., Zhang, K., Paudyal, B., Devakumar, D., Covarrubias, M. Y., Cheng, C., Gray, B. D., Wickstrom, E., and Pak, K. Y. (2012) Targeting apoptosis for optical imaging of infection Mol. Imaging Biol. 14, 163-171
29. White, A. G., Gray, B. D., Pak, K. Y., and Smith, B. D. (2012) Deep-red fluorescent imaging probe for bacteria Bioorg. Med. Chem. Lett. 22, 2833-2836
30. DiVittorio, K. M., Leevy, W. M., O'Neil, E. J., Johnson, J. R., Vakulenko, S., Morris, J. D., Rosek, K. D., Serazin, N., Hilkert, S., Hurley, S., Marquez, M., and Smith, B. D. (2008) Zinc(II) coordination complexes as membrane-active fluorescent probes and antibiotics ChemBioChem 9, 286-293
31. Johnson, J. R., Fu, N., Arunkumar, E., Leevy, W. M., Gammon, S. T., Piwnica-Worms, D., and Smith, B. D. (2007) Squaraine rotaxanes: superior substitutes for Cy-5 in molecular probes for near-infrared fluorescence cell imaging Angew. Chem., Int. Ed. Engl. 46, 5528-5531
32. White, A. G., Fu, N., Leevy, W. M., Lee, J. J., Blasco, M. A., and Smith, B. D. (2010) Optical imaging of bacterial infection in living mice using deep-red fluorescent squaraine rotaxane probes Bioconjugate Chem. 21, 1297-1304
33. Leevy, W. M., Lambert, T. N., Johnson, J. R., Morris, J., and Smith, B. D. (2008) Quantum dot probes for bacteria distinguish Escherichia coli mutants and permit in vivo imaging Chem. Commun. 2331-2333
34. Liu, X., Cheng, D., Gray, B. D., Wang, Y., Akalin, A., Rusckowski, M., Pak, K. Y., and Hnatowich, D. J. (2012) Radiolabeled Zn-DPA as a potential infection imaging agent Nucl. Med. Biol. 39, 709-714
35. Koulov, A. V., Stucker, K. A., Lakshmi, C., Robinson, J. P., and Smith, B. D. (2003) Detection of apoptotic cells using a synthetic fluorescent sensor for membrane surfaces that contain phosphatidylserine Cell Death Differ. 10, 1357-1359
36. Lakshmi, C., Hanshaw, R. G., and Smith, B. D. (2004) Fluorophore-linked zinc(II)dipicolylamine coordination complexes as sensors for phosphatidylserine-containing membranes Tetrahedron 60, 11307-11315
37. Hanshaw, R. G., Lakshmi, C., Lambert, T. N., Johnson, J. R., and Smith, B. D. (2005) Fluorescent detection of apoptotic cells by using zinc coordination complexes with a selective affinity for membrane surfaces enriched with phosphatidylserine ChemBioChem 6, 2214-2220
38. Smith, B. A., Xiao, S., Wolter, W., Wheeler, J., Suckow, M. A., and Smith, B. D. (2011) In vivo targeting of cell death using a synthetic fluorescent molecular probe Apoptosis 16, 722-731
39. Smith, B. A., Gammon, S. T., Xiao, S., Wang, W., Chapman, S., McDermott, R., Suckow, M. A., Johnson, J. R., Piwnica-Worms, D., Gokel, G. W., Smith, B. D., and Leevy, W. M. (2011) In vivo optical imaging of acute cell death using a near-infrared fluorescent zinc-dipicolylamine probe Mol. Pharm. 8, 583-590
40. Smith, B. A., Harmatys, K. M., Xiao, S., Cole, E. L., Plaunt, A. J., Wolter, W., Suckow, M. A., and Smith, B. D. (2013) Enhanced cell death imaging using multivalent zinc(II)-bis(dipicolylamine) fluorescent probes Mol. Pharmacol. 10, 3296-3303
41. Smith, B. A., Akers, W. J., Leevy, W. M., Lampkins, A. J., Xiao, S., Wolter, W., Suckow, M. A., Achilefu, S., and Smith, B. D. (2010) Optical imaging of mammary and prostate tumors in living animals using a synthetic near infrared zinc(II)-dipicolylamine probe for anionic cell surfaces J. Am. Chem. Soc. 132, 67-69
42. Park, C. B., Kim, H. S., and Kim, S. C. (1998) Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions Biochem. Biophys. Res. Commun. 244, 253-257
43. Arcidiacono, S., Pivarnik, P., Mello, C. M., and Senecal, A. (2008) Cy5 labeled antimicrobial peptides for enhanced detection of Escherichia coli O157:H7 Biosens. Bioelectron. 23, 1721-1727
44. Benincasa, M., Pacor, S., Gennaro, R., and Scocchi, M. (2009) Rapid and reliable detection of antimicrobial peptide penetration into gram-negative bacteria based on fluorescence quenching Antimicrob. Agents Chemother. 53, 3501-3504
45. Benincasa, M., Pelillo, C., Zorzet, S., Garrovo, C., Biffi, S., Gennaro, R., and Scocchi, M. (2010) The proline-rich peptide Bac7(1-35) reduces mortality from Salmonella typhimurium in a mouse model of infection BMC Microbiol. 10, 178
46. Hasper, H. E., Kramer, N. E., Smith, J. L., Hillman, J. D., Zachariah, C., Kuipers, O. P., de Kruijff, B., and Breukink, E. (2006) An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II Science 313, 1636-1637
47. Welling, M. M., Nibbering, P. H., Paulusma-Annema, A., Hiemstra, P. S., Pauwels, E. K., and Calame, W. (1999) Imaging of bacterial infections with 99mTc-labeled human neutrophil peptide-1 J. Nucl. Med. 40, 2073-2080
48. Welling, M. M., Paulusma-Annema, A., Balter, H. S., Pauwels, E. K., and Nibbering, P. H. (2000) Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations Eur. J. Nucl. Med. 27, 292-301
49. Brouwer, C. P. and Welling, M. M. (2008) Various routes of administration of (99m)Tc-labeled synthetic lactoferrin antimicrobial peptide hLF 1-11 enables monitoring and effective killing of multidrug-resistant Staphylococcus aureus infections in mice Peptides 29, 1109-1117
50. Liberatore, M., Pala, A., Scaccianoce, S., Anagnostou, C., Di Tondo, U., Calandri, E., D'Elia, P., Gross, M. D., and Rubello, D. (2009) Microbial targeting of 99mTc-labeled recombinant human beta-defensin-3 in an animal model of infection: a feasibility pilot study J. Nucl. Med. 50, 823-826
51. Welling, M. M., Brouwer, C. P., van 't Hof, W, Veerman, E. C., and Amerongen, A. V. (2007) Histatin-derived monomeric and dimeric synthetic peptides show strong bactericidal activity towards multidrug-resistant Staphylococcus aureus in vivo Antimicrob. Agents Chemother. 51, 3416-3419
52. Brouwer, C. P., Bogaards, S. J., Wulferink, M., Velders, M. P., and Welling, M. M. (2006) Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice Peptides 27, 2585-2591
53. Visentin, R., Welling, M. M., Tognetto, L., Feitsma, R. I. J., Mazzi, U., Pauwels, E. K. J., and Nibbering, P. H. (2002) Labelled antimicrobial peptide UBI 29-41: Comparison among 99mTc-UBI, 99mTc-MAG3-UBI, 123I-UBI Techn. Rhen. Other Metals Chem. Nucl. Med. 6, 695-699
54. Welling, M. M., Visentin, R., Feitsma, H. I., Lupetti, A., Pauwels, E. K., and Nibbering, P. H. (2004) Infection detection in mice using 99mTc-labeled HYNIC and N2S2 chelate conjugated to the antimicrobial peptide UBI 29-41 Nucl. Med. Biol. 31, 503-509
55. Zijlstra, S., Gunawan, J., Freytag, C., and Burchert, W. (2006) Synthesis and evaluation of fluorine-18 labelled compounds for imaging of bacterial infections with PET Appl. Radiat. Isot. 64, 802-807
56. Ebenhan, T., Govender, T., Kruger, G., Pulker, T., Zeevaart, J. R., and Sathekge, M. (2012) Synthesis of 68Ga-NOTA-UBI30-41 and in vivo biodistribution in vervet monkeys towards potential PET/CT imaging of infection J. Nucl. Med. 53 (S1) 1520
57. Liu, C. and Gu, Y. (2013) Noninvasive optical imaging of staphylococcus aureus infection in vivo using an antimicrobial peptide fragment based near-infrared fluorescent probes J. Innov. Opt. Health Sci. 6, 1350026
58. Seo, J., Ren, G., Liu, H., Miao, Z., Park, M., Wang, Y., Miller, T. M., Barron, A. E., and Cheng, Z. (2012) In vivo biodistribution and small animal PET of (64)Cu-labeled antimicrobial peptoids Bioconjugate Chem. 23, 1069-1079
59. Kuru, E., Hughes, H. V., Brown, P. J., Hall, E., Tekkam, S., Cava, F., de Pedro, M. A., Brun, Y. V., and van Nieuwenhze, M. S. (2012) In situ probing of newly synthesized peptidoglycan in live bacteria with fluorescent D-amino acids Angew. Chem., Int. Ed. Engl. 51, 12519-12523
60. Siegrist, M. S., Whiteside, S., Jewett, J. C., Aditham, A., Cava, F., and Bertozzi, C. R. (2013) d -Amino acid chemical reporters reveal peptidoglycan dynamics of an intracellular pathogen ACS Chem. Biol. 8, 500-505
61. Welling, M. M., Lupetti, A., Balter, H. S., Lanzzeri, S., Souto, B., Rey, A. M., Savio, E. O., Paulusma-Annema, A., Pauwels, E. K., and Nibbering, P. H. (2001) 99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections J. Nucl. Med. 42, 788-794
62. van Berkel, P. H., Welling, M. M., Geerts, M., van Veen, H. A., Ravensbergen, B., Salaheddine, M., Pauwels, E. K., Pieper, F., Nuijens, J. H., and Nibbering, P. H. (2002) Large scale production of recombinant human lactoferrin in the milk of transgenic cows Nat. Biotechnol. 20, 484-487
63. Welling, M. M., Mongera, S., Lupetti, A., Balter, H. S., Bonetto, V., Mazzi, U., Pauwels, E. K., and Nibbering, P. H. (2002) Radiochemical and biological characteristics of 99mTc-UBI 29-41 for imaging of bacterial infections Nucl. Med. Biol. 29, 413-422
64. Ferro-Flores, G., Arteaga de Murphy, C., Pedraza-Lopez, M., Melendez-Alafort, L., Zhang, Y. M., Rusckowski, M., and Hnatowich, D. J. (2003) In vitro and in vivo assessment of 99mTc-UBI specificity for bacteria Nucl. Med. Biol. 30, 597-603
65. Akhtar, M. S., Iqbal, J., Khan, M. A., Irfanullah, J., Jehangir, M., Khan, B., Ul-Haq, I., Muhammad, G., Nadeem, M. A., Afzal, M. S., and Imran, M. B. (2004) 99mTc-labeled antimicrobial peptide ubiquicidin (29-41) accumulates less in Escherichia coli infection than in Staphlococcus aureus infection J. Nucl. Med. 45, 849-856
66. Nibbering, P. H., Welling, M. M., Paulusma-Annema, A., Brouwer, C. P., Lupetti, A., and Pauwels, E. K. (2004) 99mTc-Labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus J. Nucl. Med. 45, 321-326
67. Sarda-Mantel, L., Saleh-Mghir, A., Welling, M. M., Meulemans, A., Vrigneaud, J. M., Raguin, O., Hervatin, F., Martet, G., Chau, F., Lebtahi, R., and Le Guludec, D. (2007) Evaluation of 99mTc-UBI 29-41 scintigraphy for specific detection of experimental Staphylococcus aureus prosthetic joint infections Eur. J. Nucl. Med. Mol. Imaging 34, 1302-1309
68. Akhtar, M. S., Khan, M. E., Khan, B., Irfanullah, J., Afzal, M. S., Khan, M. A., Nadeem, M. A., Jehangir, M., and Imran, M. B. (2008) An imaging analysis of (99m)Tc-UBI (29-41) uptake in S. aureus infected thighs of rabbits on ciprofloxacin treatment Eur. J. Nucl. Med. Mol. Imaging 35, 1056-1064
69. Brouwer, C. P., Gemmel, F. F., and Welling, M. M. (2010) Evaluation of 99mTc-UBI 29-41 scintigraphy for specific detection of experimental multidrug-resistant Staphylococcus aureus bacterial endocarditis Q. J. Nucl. Med. Mol. Imaging 54, 442-450
70. Melendez-Alafort, L., Rodriguez-Cortes, J., Ferro-Flores, G., Arteaga de Murphy, C., Herrera-Rodriguez, R., Mitsoura, E., and Martinez-Duncker, C. (2004) Biokinetics of (99m)Tc-UBI 29-41 in humans Nucl. Med. Biol. 31, 373-379
71. Akhtar, M. S., Qaisar, A., Irfanullah, J., Iqbal, J., Khan, B., Jehangir, M., Nadeem, M. A., Khan, M. A., Afzal, M. S., Ul-Haq, I., and Imran, M. B. (2005) Antimicrobial peptide 99mTc-ubiquicidin 29-41 as human infection-imaging agent: clinical trial J. Nucl. Med. 46, 567-573
72. Arteaga de Murphy, C., Gemmel, F., and Balter, J. (2010) Clinical trial of specific imaging of infections Nucl. Med. Commun. 31, 726-733
73. Sepulveda-Mendez, J., Arteaga de Murphy, C., Rojas-Bautista, J. C., and Pedraza-Lopez, M. (2010) Specificity of 99mTc-UBI for detecting infection foci in patients with fever in study Nucl. Med. Commun. 31, 889-895
74. Saeed, S., Zafar, J., Khan, B., Akhtar, A., Qurieshi, S., Fatima, S., Ahmad, N., and Irfanullah, J. (2013) Utility of (99)mTc-labelled antimicrobial peptide ubiquicidin (29-41) in the diagnosis of diabetic foot infection Eur. J. Nucl. Med. Mol. Imaging 40, 737-743
75. Nazari, B., Azizmohammadi, Z., Rajaei, M., Karami, M., Javadi, H., Assadi, M., and Asli, I. N. (2011) Role of 99mTc-ubiquicidin 29-41 scintigraphy to monitor antibiotic therapy in patients with orthopedic infection: a preliminary study Nucl. Med. Commun. 32, 745-751
76. Gandomkar, M., Najafi, R., Shafiei, M., Mazidi, M., Goudarzi, M., Mirfallah, S. H., Ebrahimi, F., Heydarpor, H. R., and Abdie, N. (2009) Clinical evaluation of antimicrobial peptide [(99m)Tc/Tricine/HYNIC(0)]ubiquicidin 29-41 as a human-specific infection imaging agent Nucl. Med. Biol. 36, 199-205
77. Ilver, D., Johansson, P., Miller-Podraza, H., Nyholm, P. G., Teneberg, S., and Karlsson, K. A. (2003) Bacterium-host protein-carbohydrate interactions Methods Enzymol. 363, 134-157
78. Mammen, M., Choi, S., and Whitesides, G. M. (1998) Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors Angew. Chem., Int. Ed. Engl. 37, 2754-2794
79. Disney, M. D., Zheng, J., Swager, T. M., and Seeberger, P. H. (2004) Detection of bacteria with carbohydrate-functionalized fluorescent polymers J. Am. Chem. Soc. 126, 13343-13346
80. Xue, C., Jog, S. P., Murthy, P., and Liu, H. (2006) Synthesis of highly water-soluble fluorescent conjugated glycopoly(p-phenylene)s for lectin and Escherichia coli Biomacromolecules 7, 2470-2474
81. Hirschey, M. D., Han, Y. J., Stucky, G. D., and Butler, A. (2006) Imaging Escherichia coli using functionalized core/shell CdSe/CdS quantum dots J. Biol. Inorg. Chem. 11, 663-669
82. Kloepfer, J. A., Mielke, R. E., Wong, M. S., Nealson, K. H., Stucky, G., and Nadeau, J. L. (2003) Quantum dots as strain- and metabolism-specific microbiological labels Appl. Environ. Microbiol. 69, 4205-4213
83. Mukhopadhyay, B., Martins, M. B., Karamanska, R., Russell, D. A., and Field, R. A. (2009) Bacterial detection using carbohydrate-functionalised CdS quantum dots: a model study exploiting E. coli recognition of mannasides Tetrahedron Lett. 50, 886-889
84. Backus, K. M., Boshoff, H. I., Barry, C. S., Boutureira, O., Patel, M. K., D'Hooge, F., Lee, S. S., Via, L. E., Tahlan, K., Barry, C. E., 3rd, and Davis, B. G. (2011) Uptake of unnatural trehalose analogs as a reporter for Mycobacterium tuberculosis Nat. Chem. Biol. 7, 228-235
85. Lankinen, P., Lehtimaki, K., Hakanen, A. J., Roivainen, A., and Aro, H. T. (2012) A comparative 18 F-FDG PET/CT imaging of experimantal Staphylococcus aureus osteomyelitis and Staphylococcus epidermidis foreign-bodyassociated infection in the rabbit tibia Eur. J. Nucl. Med. Mol. Imaging 2, 41
86. Seshadri, N., Sonoda, L. I., Lever, A. M., and Balan, K. (2012) Superiority of 18F-FDG PET compared to 111In-labelled leucocyte scintigraphy in the evaluation of fever of unknown origin J. Infect. 65, 71-79
87. Parisi, M. T. (2011) Functional imaging of infection: conventional nuclear medicine agents and the expanding role of 18-F-FDG PET Pediatr. Radiol. 41, 803-810
88. Welling, M. M. and Alberto, R. (2010) Performance of a 99mTc-labelled 1-thio-beta-D-glucose 2,3,4,6-tetra-acetate analogue in the detection of infections and tumours in mice: a comparison with [18F]FDG Nucl. Med. Commun. 31, 239-248
89. Martinez, M. E., Kiyono, Y., Noriki, S., Inai, K., Mandap, K. S., Kobayashi, M., Mori, T., Tokunaga, Y., Tiwari, V. N., Okazawa, H., Fujibayashi, Y., and Ido, T. (2011) New radiosynthesis of 2-deoxy-2-[(18)F]fluoroacetamido-D- glucopyranose and its evaluation as a bacterial infections imaging agent Nucl. Med. Biol. 38, 807-817
90. Bettegowda, C., Foss, C. A., Cheong, I., Wang, Y., Diaz, L., Agrawal, N., Fox, J., Dick, J., Dang, L. H., Zhou, S., Kinzler, K. W., Vogelstein, B., and Pomper, M. G. (2005) Imaging bacterial infections with radiolabeled 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil Proc. Natl. Acad. Sci. U.S.A. 102, 1145-1150
91. Diaz, L. A., Jr., Foss, C. A., Thornton, K., Nimmagadda, S., Endres, C. J., Uzuner, O., Seyler, T. M., Ulrich, S. D., Conway, J., Bettegowda, C., Agrawal, N., Cheong, I., Zhang, X., Ladenson, P. W., Vogelstein, B. N., Mont, M. A., Zhou, S., Kinzler, K. W., Vogelstein, B., and Pomper, M. G. (2007) Imaging of musculoskeletal bacterial infections by [124I]FIAU-PET/CT PLoS One 2, e1007
92. Pullambhatla, M., Tessier, J., Beck, G., Jedynak, B., Wurthner, J. U., and Pomper, M. G. (2012) [125I]FIAU imaging in a preclinical model of lung infection: quantification of bacterial load Am. J. Nucl. Med. Mol. Imaging 2, 260-270
93. Jang, S. J., Lee, Y. J., Lim, S., Kim, K. I., Lee, K. C., An, G. I., Lee, T. S., Cheon, G. J., Lim, S. M., and Kang, J. H. (2012) Imaging of a localized bacterial infection with endogenous thymidine kinase using radioisotope-labeled nucleosides Int. J. Med. Microbiol. 302, 101-107
94. Ning, X., Lee, S., Wang, Z., Kim, D., Stubblefield, B., Gilbert, E., and Murthy, N. (2011) Maltodextrin-based imaging probes detect bacteria in vivo with high sensitivity and specificity Nat. Mater. 10, 602-607
95. Shukla, J., Arora, G., Kotwal, P. P., Kumar, R., Malhotra, A., and Bandopadhyaya, G. P. (2010) Radiolabeled oligosaccharides nanoprobes for infection imaging Hell. J. Nucl. Med. 13, 218-223
96. Dumont, A., Malleron, A., Awwad, M., Dukan, S., and Vauzeilles, B. (2012) Click-mediated labeling of bacterial membranes through metabolic modification of the lipopolysaccharide inner core Angew. Chem., Int. Ed. Engl. 51, 3143-3146
97. Swarts, B. M., Holsclaw, C. M., Jewett, J. C., Alber, M., Fox, D. M., Siegrist, M. S., Leary, J. A., Kalscheuer, R., and Bertozzi, C. R. (2012) Probing the Mycobacterial trehalome with bioorthogonal chemistry J. Am. Chem. Soc. 134, 16123-16126
98. Jewett, J. C. and Bertozzi, C. R. (2010) Cu-free click cycloaddition reactions in chemical biology Chem. Soc. Rev. 39, 1272-1279
99. Bakheet, S. M. and Powe, J. (2000) Benign causes of 18-FDG uptake on whole body imaging Sem. Nucl. Med. 28, 352-358
100. Treglia, G., Taralli, S., Calcagni, M. L., Maggi, F., Giordano, A., and Bonomo, L. (2011) Is there a role for fluorine 18 fluorodeoxyglucose-positron emission tomography and positron emission tomography/computed tomography in evaluating patients with mycobacteriosis? A systematic review J. Comput. Assist. Tomogr. 35, 387-393
101. Ren, W., Muzik, O., Jackson, N., Khoury, B., Shi, T., Flynn, J. C., Chakraborty, P., and Markel, D. C. (2012) Differentiation of septic and aseptic loosening by PET with both 11C-PK11195 and 18F-FDG in rat models Nucl. Med. Commun. 33, 747-756
102. Peterson, K. L., Reid, W. C., Freeman, A. F., Holland, S. M., Pettigrew, R. I., Gharib, A. M., and Hammoud, D. A. (2013) The use of (14)C-FIAU to predict bacterial thymidine kinase presence: Implications for radiolabeled FIAU bacterial imaging Nucl. Med. Biol. 40, 638-642
103. Been, L. B., Suurmeijer, A. J., Cobben, D. C., Jager, P. L., Hoekstra, H. J., and Elsinga, P. H. (2004) [18F]FLT-PET in oncology: current status and opportunities Eur. J. Nucl. Med. Mol. Imaging 31, 1659-1672
104. Tiyanont, K., Doan, T., Lazarus, M. B., Fang, X., Rudner, D. Z., and Walker, S. (2006) Imaging peptidoglycan biosynthesis in Bacillus subtilis with fluorescent antibiotics Proc. Natl. Acad. Sci. U.S.A. 103, 11033-11038
105. Pereira, P. M., Filipe, S. R., Tomasz, A., and Pinho, M. G. (2007) Fluorescence ratio imaging microscopy shows decreased access of vancomycin to cell wall synthetic sites in vancomycin-resistant Staphylococcus aureus Antimicrob. Agents Chemother. 51, 3627-3633
106. Lunde, C. S., Rexer, C. H., Hartouni, S. R., Axt, S., and Benton, B. M. (2010) Fluorescence microscopy demonstrates enhanced targeting of telavancin to the division septum of Staphylococcus aureus Antimicrob. Agents Chemother. 54, 2198-2200
107. Kao, J. C., Geroski, D. H., and Edelhauser, H. F. (2005) Transscleral permeability of fluorescent-labeled antibiotics J. Ocul. Pharmacol. Ther. 21, 1-10
108. Dhanapal, R., Perumal, P. T., Damodiran, M., Ramprasath, C., and Mathivanan, N. (2012) Synthesis of quinoline derivatives for fluorescent imaging certain bacteria Bioorg. Med. Chem. Lett. 22, 6494-6497
109. Fischman, A. J., Livni, E., Babich, J., Alpert, N. M., Liu, Y. Y., Thom, E., Cleeland, R., Prosser, B. L., Callahan, R. J., and Correia, J. A. 1992, Pharmacokinetics of 18F-labeled fleroxacin in rabbits with Escherichia coli infections, studied with positron emission tomography Antimicrob. Agents Chemother. 36, 2286-2292
110. Livni, E., Babich, J., Alpert, N. M., Liu, Y. Y., Thom, E., Cleeland, R., Prosser, B. L., Correia, J. A., Strauss, H. W., and Rubin, R. H. 1993, Synthesis and biodistribution of 18F-labeled fleroxacin Nucl. Med. Biol. 20, 81-87
111. Tewson, T. J., Yang, D., Wong, G., Macy, D., DeJesus, O. J., Nickles, R. J., Perlman, S. B., Taylor, M., and Frank, P. (1996) The synthesis of fluorine-18 lomefloxacin and its preliminary use in human studies Nucl. Med. Biol. 23, 767-772
112. Motaleb, M. A. (2007) Preparation and biodistribution of 99mTc-lomefloxacin and 99mTc-ofloxacin complexes J. Radioanal. Nucl. Chem. 272, 95-99
113. Babich, J. W., Rubin, R. H., Graham, W. A., Wilkinson, R. A., Vincent, J., and Fischman, A. J. (1996) 18F-labeling and biodistribution of the novel fluoro-quinolone antimicrobial agent, trovafloxacin (CP 99,219) Nucl. Med. Biol. 23, 995-998
114. Fischman, A. J., Babich, J. W., Bonab, A. A., Alpert, N. M., Vincent, J., Callahan, R. J., Correia, J. A., and Rubin, R. H. (1998) Pharmacokinetics of [18F]trovafloxacin in healthy human subjects studied with positron emission tomography Antimicrob. Agents Chemother. 42, 2048-2054
115. Singh, A. K., Verma, J., Bhatnagar, A., and Ali, A. (2003) Tc-99m labeled sparfloxacin: A specific infection imaging agent World J. Nucl. Med. 2, 103-109
116. Siaens, R. H., Rennen, H. J., Boerman, O. C., Dierckx, R., and Slegers, G. (2004) Synthesis and comparison of 99mTc-enrofloxacin and 99mTc-ciprofloxacin J. Nucl. Med. 45, 2088-2094
117. El-Ghany, E. A., El-Kolaly, M. T., Amine, A. M., El-Sayed, A. S., and Abdel-Gelil, G. (2005) Synthesis of 99mTc-pefloxacin: A new targeting agent for infectious foci J. Radioanal. Nucl. Chem. 266, 131-139
118. El-Ghany, E. A., Amine, A. M., El-Kawy, O. A., and Amin, M. (2007) Technetium-99m labeling and freeze-dried kit formulation of levofloxacin (L-Flox): A novel agent for detecting sites of infection J. Label. Compd. Radiopharm. 50, 25-31
119. Qaiser, S. S., Khan, A. U., and Khan, M. R. (2010) Synthesis, biodistribution and evaluation of 99mTc-sitafloxacin kit: a novel infection imaging agent J. Radioanal. Nucl. Chem. 284, 189-193
120. Shah, S. Q. and Khan, M. R. (2011) Radiosynthesis and biological evaluation of the (99m)Tc-tricarbonyl moxifloxacin dithiocarbamate complex as a potential Staphylococcus aureus infection radiotracer Appl. Radiat. Isot. 69, 686-690
121. Ibrahim, I. T., Motaleb, M. A., and Attalah, K. M. (2010) Synthesis and biological distribution of Tc-99m-norfloxacin complex, a novel agent for detecting sites of infection J. Radioanal. Nucl. Chem. 285, 431-436
122. Zhang, S., Zhang, W., Wang, Y., Jin, Z., Wang, X., Zhang, J., and Zhang, Y. (2011) Synthesis and biodistribution of a novel (99m)TcN complex of norfloxacin dithiocarbamate as a potential agent for bacterial infection imaging Bioconjugate Chem. 22, 369-375
123. Shah, S. Q. and Khan, M. R. (2011) Synthesis of technetium-99m labeled clinafloxacin (99mTc-CNN) complex and biological evaluation as a potential Staphylococcus aureus infection imaging agent J. Radioanal. Nucl. Chem. 288, 423-428
124. Motaleb, M. A. (2010) Radiochemical and biological characteristics of 99mTc-difloxacin and 99mTc-pefloxacin for detecting sites of infection J. Label. Compd. Radiopharm. 53, 104-109
125. Barreto, G. V., Iglesias, F., Roca, M., Tubau, F., and Martin-Comin, J. (2000) Labelling of ceftizoxime with 99mTc Rev. Esp. Med. Nucl. 19, 479-483
126. Diniz, S. O., Rezende, C. M., Serakides, R., Ferreira, R. L., Ribeiro, T. G., Martin-Comin, J., and Cardoso, V. N. (2008) Scintigraphic imaging using technetium-99m-labeled ceftizoxime in an experimental model of acute osteomyelitis in rats Nucl. Med. Commun. 29, 830-836
127. Motaleb, M. A. (2007) Preparation of 99mTc-cefoperazone complex, a novel agent for detecting sites of infection J. Radioanal. Nucl. Chem. 272, 167-171
128. Lambrecht, F. Y., Durkan, K., and Unak, P. (2007) Preparation, quality control and stability of 99mTc-cefuroxime axetil J. Radioanal. Nucl. Chem. 275, 161-164
129. Lambrecht, F. Y., Yilmaz, O., Unak, P., Seyitoglu, B., Durkan, K., and Baskan, H. (2008) Evaluation of 99mTc-Cefuroxime axetil for imaging of inflammation J. Radioanal. Nucl. Chem. 277, 491-494
130. Chattopadhyay, S., Ghosh, M., Sett, S., Das, M. K., Chandra, S., De, K., Mishra, M., Sinha, S., Ranjan Sarkar, B., and Ganguly, S. (2012) Preparation and evaluation of 99mTc-cefuroxime, a potential infection specific imaging agent: a reliable thin layer chromatographic system to delineate impurities from the 99mTc-antibiotic Appl. Radiat. Isot. 70, 2384-2387
131. Motaleb, M. A., El-Kolaly, M. T., Ibrahim, A. B., and Abd El-Bary, A. (2011) Study on the preparation and biological evaluation of 99mTc-gatifloxacin and 99mTc-cefepime complex J. Radioanal. Nucl. Chem. 289, 57-65
132. Mostafa, M., Motaleb, M. A., and Sakr, T. M. (2010) Labeling of ceftriaxone for infective inflammation imaging using 99mTc eluted from 99Mo/99mTc generator based on zirconium molybdate Appl. Radiat. Isot. 68, 1959-1963
133. Kaul, A., Hazari, P. P., Rawat, H., Singh, B., Kalawat, T. C., Sharma, S., Babbar, A. K., and Mishra, A. K. (2012) Preliminary evaluation of technetium-99m-labeled ceftriaxone: infection imaging agent for the clinical diagnosis of orthopedic infection Int. J. Infect. Dis. 17, e263-e270
134. Ercan, M. T., Aras, T., and Unsal, I. S. (1992) Evaluation of 99mTc-erythromycin and 99mTc-streptomycin sulphate for the visualization of inflammatory lesions Int. J. Rad. Appl. Instrum. B 19, 803-806
135. Roohi, S., Mushtaq, A., Jehangir, M., and Malik, S. A. (2006) Synthesis, quality control and biodistribution of 99mTc-Kanamycin J. Radioanal. Nucl. Chem. 267, 561-566
136. Tsopelas, C., Penglis, S., Ruszkiewicz, A., and Bartholomeusz, F. D. (2003) 99mTc-alafosfalin: an antibiotic peptide infection imaging agent Nucl. Med. Biol. 30, 169-175
137. Shah, S. Q., Khan, A. U., and Khan, M. R. (2010) Radiosynthesis and biodistribution of (99m)Tc-rifampicin: a novel radiotracer for in-vivo infection imaging Appl. Radiat. Isot. 68, 2255-2260
138. Ocakoglu, K., Bayrak, E., Onursal, M., Yilmaz, O., Lambrecht, F. Y., and Holzwarth, A. R. (2011) Evaluation of 99mTc-Pheophorbide-a use in infection imaging: a rat model Appl. Radiat. Isot. 69, 1165-1168
139. Halder, K. K., Nayak, D. K., Baishya, R., Sarkar, B. R., Sinha, S., Ganguly, S., and Debnath, M. C. (2011) (99m)Tc-labeling of ciprofloxacin and nitrofuryl thiosemicarbazone using fac-[(99m)Tc(CO)3(H2O)3] core: evaluation of their efficacy as infection imaging agents Metallomics 3, 1041-1048
140. Shah, S. Q., Khan, A. U., and Khan, M. R. (2011) Radiosynthesis of 99mTc-nitrofurantoin a novel radiotracer for in vivo imaging of Escherichia coli infection J. Radioanal. Nucl. Chem. 287, 417-422
141. Asikoglu, M., Yurt, F., Cagliyan, O., Unak, P., and Ozkilic, H. (2000) Detecting inflammation with 131I-labeled ornidazole Appl. Radiat. Isot. 53, 411-413
142. Rossouw, D. D., Lotter, M. G., du Raan, H., Jansen, S. E., Hohn, A., and Burger, B. V. (2005) Radiosynthesis and evaluation of two novel 123I-labeled 2-methyl-4-nitroimidazole derivatives as potential infection imaging agents Nucl. Med. Biol. 32, 385-394
143. Lambrecht, F. Y., Yilmaz, O., Durkan, K., Unak, P., and Bayrak, E. (2009) Preparation and biodistribution of [131I]linezolid in animal model infection and inflammation J. Radioanal. Nucl. Chem. 281, 415-419
144. Essouissi, I., Ghali, W., Saied, N. M., and Saidi, M. (2010) Synthesis and evaluation of 99mTc-N-sulfanilamide ferrocene carboxamide as bacterial infections detector Nucl. Med. Biol. 37, 821-829
145. Singh, A. K., Verma, J., Bhatnagar, A., Sen, S., and Bose, M. (2003) Tc-99m Isoniazid: A specific agent for diagnosis of tuberculosis World J. Nucl. Med. 2, 292-305
146. Hazari, P. P., Chuttani, K., Kumar, N., Mathur, R., Sharma, R., Singh, B., and Mishra, A. K. (2009) Synthesis and biological evaluation of isonicotinic acid hydrazide conjugated with diethyelenetriaminepentaacetic acid for infection imaging Open Nucl. Med. J. 1, 33-42
147. Perkins, H. R. and Nieto, M. (1970) The preparation of iodinated vancomycin and its distribution in bacteria treated with the antibiotic Biochem. J. 116, 83-92
148. Roohi, S., Mushtaq, A., and Malik, S. A. (2005) Synthesis and biodistribution of 99mTc-Vancomycin in a model of bacterial infection Radiochim. Acta 93, 415-418
149. Jalilian, A. R., Hosseini, M. A., Karimian, A., Saddadi, F., and Sadeghi, M. (2006) Preparation and biodistribution of [201TI](III)vancomycin complex in normal rats Nukleonika 51, 203-208
150. Jalilian, A. R., Hosseini, M. A., Majdabadi, A., and Saddadi, F. (2008) Evaluation of [(201)Tl](III) Vancomycin in normal rats Nucl. Med. Rev. Cent. East. Eur. 11, 1-4
151. Chung, H. J., Reiner, T., Budin, G., Min, C., Liong, M., Issadore, D., Lee, H., and Weissleder, R. (2011) Ubiquitous detection of gram-positive bacteria with bioorthogonal magnetofluorescent nanoparticles ACS Nano 5, 8834-8841
152. Solanki, K. K., Bomanji, J., Siraj, Q., Small, M., and Britton, K. E. (1993) 99mTc-infecton: A new class of radiopharmaceutical for imaging infection J. Nucl. Med. 34, 119P
153. Vinjamuri, S., Hall, A. V., Solanki, K. K., Bomanji, J., Siraj, Q., O'Shaughnessy, E., Das, S. S., and Britton, K. E. (1996) Comparison of 99mTc infecton imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection Lancet 347, 233-235
154. Britton, K. E., Wareham, D. W., Das, S. S., Solanki, K. K., Amaral, H., Bhatnagar, A., Katamihardja, A. H., Malamitsi, J., Moustafa, H. M., Soroa, V. E., Sundram, F. X., and Padhy, A. K. (2002) Imaging bacterial infection with (99m)Tc-ciprofloxacin (Infecton) J. Clin. Pathol. 55, 817-823
155. Britton, K. E., Vinjamuri, S., Hall, A. V., Solanki, K., Siraj, Q. H., Bomanji, J., and Das, S. (1997) Clinical evaluation of technetium-99m infecton for the localisation of bacterial infection Eur. J. Nucl. Med. 24, 553-556
156. Hall, A. V., Solanki, K. K., Vinjamuri, S., Britton, K. E., and Das, S. S. (1998) Evaluation of the efficacy of 99mTc-Infecton, a novel agent for detecting sites of infection J. Clin. Pathol. 51, 215-219
157. Malamitsi, J., Giamarellou, H., Kanellakopoulou, K., Dounis, E., Grecka, V., Christakopoulos, J., Koratzanis, G., Antoniadou, A., Panoutsopoulos, G., Batsakis, C., and Proukakis, C. (2003) Infecton: a 99mTc-ciprofloxacin radiopharmaceutical for the detection of bone infection Clin. Microbiol. Infect. 9, 101-109
158. Choe, Y. M., Choe, W., Lee, K. Y., Ahn, S. I., Kim, K., Cho, Y. U., Choi, S. K., Hur, Y. S., Kim, S. J., Hong, K. C., Shin, S. H., Kim, K. R., and Woo, Z. H. (2007) Tc-99m ciprofloxacin imaging in acute cholecystitis World J. Gastroenterol. 13, 3249-3252
159. Sarda, L., Saleh-Mghir, A., Peker, C., Meulemans, A., Cremieux, A. C., and Le Guludec, D. (2002) Evaluation of (99m)Tc-ciprofloxacin scintigraphy in a rabbit model of Staphylococcus aureus prosthetic joint infection J. Nucl. Med. 43, 239-245
160. Sarda, L., Cremieux, A. C., Lebellec, Y., Meulemans, A., Lebtahi, R., Hayem, G., Genin, R., Delahaye, N., Huten, D., and Le Guludec, D. (2003) Inability of 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases J. Nucl. Med. 44, 920-926
161. Sharma, R., Tewari, K. N., Bhatnagar, A., Mondal, A., Mishra, A. K., Singh, A. K., Chopra, M. K., Rawat, H., Kashyap, R., and Tripathi, R. P. (2007) Tc-99m ciprofloxacin scans for detection of tubercular bone infection Clin. Nucl. Med. 32, 367-370
162. Palestro, C. J., Love, C., Caprioli, R., Marwin, S., Richardson, H., Haight, J., Tronco, G., Pugliese, P., and Bhargava, K. (2006) Phase II study of 99mTc-ciprofloxacin uptake in patients with high suspicion of osteomyelitis J. Nucl. Med. 1, 152P
163. Langer, O., Mitterhauser, M., Brunner, M., Zeitlinger, M., Wadsak, W., Mayer, B. X., Kletter, K., and Muller, M. (2003) Synthesis of fluorine-18-labeled ciprofloxacin for PET studies in humans Nucl. Med. Biol. 30, 285-291
164. Langer, O., Brunner, M., Zeitlinger, M., Ziegler, S., Muller, U., Dobrozemsky, G., Lackner, E., Joukhadar, C., Mitterhauser, M., Wadsak, W., Minar, E., Dudczak, R., Kletter, K., and Muller, M. (2005) In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PET Eur. J. Nucl. Med. Mol. Imaging 32, 143-150
165. Sachin, K., Kim, E. M., Cheong, S. J., Jeong, H. J., Lim, S. T., Sohn, M. H., and Kim, D. W. (2010) Synthesis of N'-[(18)F]fluoroalkylated ciprofloxacin as a potential bacterial infection imaging agent for PET study Bioconjugate Chem. 21, 2282-2288
166. Zhang, J., Guo, H., Zhang, S., Lin, Y., and Wang, X. (2008) Synthesis and biodistribution of a novel (99m)TcN complex of ciprofloxacin dithiocarbamate as a potential agent for infection imaging Bioorg. Med. Chem. Lett. 18, 5168-5170
167. Dahiya, S., Chuttani, K., Khar, R. K., Saluja, D., Mishra, A. K., and Chopra, M. (2009) Synthesis and evaluation of Ciprofloxacin derivatives as diagnostic tools for bacterial infection by Staphylococcus aureus Metallomics 1, 409-417
168. Kohanski, M. A., DePristo, M. A., and Collins, J. J. (2010) Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis Mol. Cell 37, 311-320
169. Namura, M., Hijikata, T., Miyanaga, K., and Tanji, Y. (2008) Detection of Escherichia coli with fluorescent labeled phages that have a broad host range to E. coli in sewage water Biotechnol. Prog. 24, 481-486
170. Oda, M., Morita, M., Unno, H., and Tanji, Y. (2004) Rapid detection of Escherichia coli O157:H7 by using green fluorescent protein-labeled PP01 bacteriophage Appl. Environ. Microbiol. 70, 527-534
171. Mosier-Boss, P. A., Lieberman, S. H., Andrews, J. M., Rohwer, F. L., Wegley, L. E., and Breitbart, M. (2003) Use of fluorescently labeled phage in the detection and identification of bacterial species Appl. Spectrosc. 57, 1138-1144
172. Lee, S. H., Onuki, M., Satoh, H., and Mino, T. (2006) Isolation, characterization of bacteriophages specific to Microlunatus phosphovorus and their application for rapid host detection Lett. Appl. Microbiol. 42, 259-264
173. Goodridge, L., Chen, J., and Griffiths, M. (1999) The use of a fluorescent bacteriophage assay for detection of Escherichia coli O157:H7 in inoculated ground beef and raw milk Int. J. Food Microbiol. 47, 43-50
174. Rusckowski, M., Gupta, S., Liu, G., Dou, S., and Hnatowich, D. J. (2004) Investigations of a (99m)Tc-labeled bacteriophage as a potential infection-specific imaging agent J. Nucl. Med. 45, 1201-1208
175. Rusckowski, M., Gupta, S., Liu, G., Dou, S., and Hnatowich, D. J. (2008) Investigation of four (99m)Tc-labeled bacteriophages for infection-specific imaging Nucl. Med. Biol. 35, 433-440
176. Wu, L., Huang, T., Yang, L., Pan, J., Zhu, S., and Yan, X. (2011) Sensitive and selective bacterial detection using tetracysteine-tagged phages in conjunction with biarsenical dye Angew. Chem., Int. Ed. Engl. 50, 5873-5877
177. Edgar, R., McKinstry, M., Hwang, J., Oppenheim, A. B., Fekete, R. A., Giulian, G., Merril, C., Nagashima, K., and Adhya, S. (2006) High-sensitivity bacterial detection using biotin-tagged phage and quantum-dot nanocomplexes Proc. Natl. Acad. Sci. U.S.A. 103, 4841-4845
178. Gomes, J., Huber, N., Grunau, A., Eberl, L., and Gademann, K. (2013) Fluorescent labeling agents for quorum-sensing receptors (FLAQS) in live cells Chemistry 19, 9766-9770
179. Zlokarnik, G., Negulescu, P. A., Knapp, T. E., Mere, L., Burres, N., Feng, L., Whitney, M., Roemer, K., and Tsien, R. Y. (1998) Quantitation of transcription and clonal selection of single living cells with beta-lactamase as reporter Science 279, 84-88
180. Gao, W., Xing, B., Tsien, R. Y., and Rao, J. (2003) Novel fluorogenic substrates for imaging beta-lactamase gene expression J. Am. Chem. Soc. 125, 11146-11147
181. Xing, B., Khanamiryan, A., and Rao, J. (2005) Cell-permeable near-infrared fluorogenic substrates for imaging beta-lactamase activity J. Am. Chem. Soc. 127, 4158-4159
182. Kong, Y., Yao, H., Ren, H., Subbian, S., Cirillo, S. L., Sacchettini, J. C., Rao, J., and Cirillo, J. D. (2010) Imaging tuberculosis with endogenous beta-lactamase reporter enzyme fluorescence in live mice Proc. Natl. Acad. Sci. U.S.A. 107, 12239-12244
183. Kong, Y. and Cirillo, J. D. (2010) Reporter enzyme fluorescence (REF) imaging and quantification of tuberculosis in live animals Virulence 1, 558-562
184. Rukavishnikov, A., Gee, K. R., Johnson, I., and Corry, S. (2011) Fluorogenic cephalosporin substrates for beta-lactamase TEM-1 Anal. Biochem. 419, 9-16
185. Zhang, J., Shen, Y., May, S. L., Nelson, D. C., and Li, S. (2012) Ratiometric fluorescence detection of pathogenic bacteria resistant to broad-spectrum b-lactam antibiotics Angew. Chem., Int. Ed. Engl. 51, 1865-1868
186. Kaman, W. E., Hulst, A. G., van Alphen, P. T., Roffel, S., van der Schans, M. J., Merkel, T., van Belkum, A., and Bikker, F. J. (2011) Peptide-based fluorescence resonance energy transfer protease substrates for the detection and diagnosis of Bacillus species Anal. Chem. 83, 2511-2517
187. Kaman, W. E., Galassi, F., de Soet, J. J., Bizzarro, S., Loos, B. G., Veerman, E. C., van Belkum, A., Hays, J. P., and Bikker, F. J. (2012) Highly specific protease-based approach for detection of porphyromonas gingivalis in diagnosis of periodontitis J. Clin. Microbiol. 50, 104-112
188. Shah, S. Q., Khan, A. U., and Khan, M. R. (2011) (99m)Tc-prulifloxacin in artificially infected animals. Radiosynthesis and biological evaluation Nuklearmedizin. Nucl. Med. 50, 134-140
189. Kruger, R. G., Dostal, P., and McCafferty, D. G. (2002) An economical and preparative orthogonal solid phase synthesis of fluorescein and rhodamine derivatized peptides: FRET substrates for the Staphylococcus aureus sortase SrtA transpeptidase reaction Chem. Commun. 2092-2093
190. Ton-That, H., Mazmanian, S. K., Faull, K. F., and Schneewind, O. (2000) Anchoring of surface proteins to the cell wall of Staphylococcus aureus. Sortase catalyzed in vitro transpeptidation reaction using LPXTG peptide and NH(2)-Gly(3) substrates J. Biol. Chem. 275, 9876-9881
191. Ilangovan, U., Ton-That, H., Iwahara, J., Schneewind, O., and Clubb, R. T. (2001) Structure of sortase, the transpeptidase that anchors proteins to the cell wall of Staphylococcus aureus Proc. Natl. Acad. Sci. U.S.A. 98, 6056-6061
192. Kruger, R. G., Dostal, P., and McCafferty, D. G. (2004) Development of a high-performance liquid chromatography assay and revision of kinetic parameters for the Staphylococcus aureus sortase transpeptidase SrtA Anal. Biochem. 326, 42-48
193. Kruger, R. G., Barkallah, S., Frankel, B. A., and McCafferty, D. G. (2004) Inhibition of the Staphylococcus aureus sortase transpeptidase SrtA by phosphinic peptidomimetics Bioorg. Med. Chem. 12, 3723-3729
194. Chenna, B. C., Shinkre, B. A., King, J. R., Lucius, A. L., Narayana, S. V., and Velu, S. E. (2008) Identification of novel inhibitors of bacterial surface enzyme Staphylococcus aureus Sortase A Bioorg. Med. Chem. Lett. 18, 380-385
195. Nelson, J. W., Chamessian, A. G., McEnaney, P. J., Murelli, R. P., Kazmierczak, B. I., and Spiegel, D. A. (2010) A biosynthetic strategy for re-engineering the Staphylococcus aureus cell wall with non-native small molecules ACS Chem. Biol. 5, 1147-1155
196. Zaytsev, A. V., Anderson, R. J., Bedernjak, A., Groundwater, P. W., Huang, Y., Perry, J. D., Orenga, S., Roger-Dalbert, C., and James, A. (2008) Synthesis and testing of chromogenic phenoxazinone substrates for beta-alanyl aminopeptidase Org. Biomol. Chem. 6, 682-692
197. Varadi, L., Gray, M., Groundwater, P. W., Hall, A. J., James, A. L., Orenga, S., Perry, J. D., and Anderson, R. J. (2012) Synthesis and evaluation of fluorogenic 2-amino-1,8-naphthyridine derivatives for the detection of bacteria Org. Biomol. Chem. 10, 2578-2589
198. Morita, T., Kato, H., Iwanaga, S., Takada, K., and Kimura, T. (1977) New fluorogenic substrates for alpha-thrombin, factor Xa, kallikreins, and urokinase J. Biochem. 82, 1495-1498
199. Holliday, M. G., Ford, M., Perry, J. D., and Gould, F. K. (1999) Rapid identification of Staphylococcus aureus by using fluorescent staphylocoagulase assays J. Clin. Microbiol. 37, 1190-1192
200. Sinclair, A., Mulcahy, L. E., Geldeard, L., Malik, S., Fielder, M. D., and Le Gresley, A. (2013) Development of an in situ culture-free screening test for the rapid detection of Staphylococcus aureus within healthcare environments Org. Biomol. Chem. 11, 3307-3313
201. Smith, W., Hale, J. H., and Smith, M. M. (1947) The role of coagulase in staphylococcal infections Br. J. Exp. Pathol. 28, 57-67
202. Panizzi, P., Nahrendorf, M., Figueiredo, J. L., Panizzi, J., Marinelli, B., Iwamoto, Y., Keliher, E., Maddur, A. A., Waterman, P., Kroh, H. K., Leuschner, F., Aikawa, E., Swirski, F. K., Pittet, M. J., Hackeng, T. M., Fuentes-Prior, P., Schneewind, O., Bock, P. E., and Weissleder, R. (2011) In vivo detection of Staphylococcus aureus endocarditis by targeting pathogen-specific prothrombin activation Nat. Med. 17, 1142-1146
203. Lee, S., Park, K., Kim, K., Choi, K., and Kwon, I. C. (2008) Activatable imaging probes with amplified fluorescent signals Chem. Commun. 4250-4260
204. Urano, Y., Sakabe, M., Kosaka, N., Ogawa, M., Mitsunaga, M., Asanuma, D., Kamiya, M., Young, M. R., Nagano, T., Choyke, P. L., and Kobayashi, H. (2011) Rapid Cancer Detection by Topically Spraying a gamma-Glutamyltranspeptidase- Activated Fluorescent Probe Sci. Transl. Med. 3, 1-10
205. Troyan, S. L., Kianzad, V., Gibbs-Strauss, S. L., Gioux, S., Matsui, A., Oketokoun, R., Ngo, L., Khamene, A., Azar, F., and Frangioni, J. V. (2009) The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping Ann. Surg. Oncol. 16, 2943-2952
206. Themelis, G., Yoo, J. S., Soh, K. S., Schulz, R., and Ntziachristos, V. (2009) Real-time intraoperative fluorescence imaging system using light-absorption correction J. Biomed. Opt. 14, 064012
207. Chin, P. T. K., Beekman, C. A. C., Buckle, T., Josephson, L., and van Leeuwen, F. W. B. (2012) Multispectral visualization of surgical safety-margins using fluorescent marker seeds Am. J. Nucl. Med. Mol. Imaging 2, 151-162
208. Evans, R. G., Naidu, B., Rajpoot, N. M., Epstein, D., and Khan, M. (2012) Toponome imaging system: multiplex biomarkers in oncology Trends Mol. Med. 18, 723-731
209. Chin, P. T. K., Welling, M. M., Meskers, S. C., Valdes Olmos, R. A., Tanke, H., and van Leeuwen, F. W. B. (2013) Optical imaging as an expansion of nuclear medicine: Cerenkov-based luminescence vs fluorescence-based luminescence Eur. J. Nucl. Med. Mol. Imaging 40, 1283-1291
210. Van den Berg, N. S., Valdes Olmos, R. A., Van der Poel, H. G., and van leeuwen, F. W. B. (2013) Sentinel lymph node biopsy for prostate cancer: a hybrid approach J. Nucl. Med. 54, 493-496
211. Buckle, T., Kuil, J., Van den Berg, N. S., Bunschoten, A., Lamb, H. J., Yuan, H., Josephson, L., Jonkers, J., Borowsky, A. D., and van Leeuwen, F. W. B. (2013) Use of a single hybrid imaging agent for integration of target validation with in vivo and ex vivo imaging of mouse tumor lesions resembling human DCIS PLoS One 8, e48324
212. Welling, M. M., Ferro-Flores, G., Pirmettis, I., and Brouwer, C. P. J. M. (2009) Current status of imaging infections with radiolabeled anti-infective agents Anti-Infect. Agents Med. Chem. 8, 272-287